We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

80 hedge funds and large institutions have $206M invested in Tempest Therapeutics in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 17 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more capital invested

Capital invested by funds: $149M → $206M (+$56.9M)

35% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 17

6% less funds holding

Funds holding: 85 → 80 (-5)

35% less call options, than puts

Call options by funds: $160K | Put options by funds: $247K

36% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 14

Holders
80
Holders Change
-5
Holders Change %
-5.88%
% of All Funds
2.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
23
Reduced
17
Closed
14
Calls
$160K
Puts
$247K
Net Calls
-$87K
Net Calls Change
+$121K

Top Buyers

Rank Fund Capital Flow
1
PCM
Portolan Capital Management
Massachusetts
+$2.86M
2
Northern Trust
Northern Trust
Illinois
+$1.79M
3
Deutsche Bank
Deutsche Bank
Germany
+$1.18M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$778K
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$633K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$2.3M
2
Marshall Wace
Marshall Wace
United Kingdom
-$1.47M
3
Invesco
Invesco
Georgia
-$961K
4
Jennison Associates
Jennison Associates
New York
-$760K
5
Millennium Management
Millennium Management
New York
-$712K
Name Holding Trade Value Shares
Change 		Change in
Stake
ERSOT
26
Employees Retirement System of Texas
Texas
$644K +$217K +12 +63%
Citigroup
27
Citigroup
New York
$623K +$163K +9 +43%
BCM
28
Bridgeway Capital Management
Texas
$609K +$362K +20 +222%
Wells Fargo
29
Wells Fargo
California
$605K – – –
PP
30
PDT Partners
New York
$557K +$488K +27 New
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$475K – – –
Charles Schwab
32
Charles Schwab
California
$442K – – –
OC
33
Oppenheimer & Co
New York
$393K +$18.1K +1 +6%
AllianceBernstein
34
AllianceBernstein
Tennessee
$362K -$36.2K -2 -11%
SM
35
Sabby Management
Florida
$358K -$525K -29 -63%
AIC
36
AWM Investment Company
New York
$358K – – –
SIP
37
Stoneridge Investment Partners
Pennsylvania
$356K – – –
HCM
38
Highbridge Capital Management
New York
$350K +$308K +17 New
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$345K – – –
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$319K – – –
Swiss National Bank
41
Swiss National Bank
Switzerland
$319K – – –
TA
42
Teachers Advisors
New York
$319K – – –
Morgan Stanley
43
Morgan Stanley
New York
$319K +$127K +7 +88%
GS
44
Gagnon Securities
New York
$307K +$271K +15 New
PPA
45
Parametric Portfolio Associates
Washington
$286K +$18.1K +1 +8%
NI
46
Numeric Investors
Massachusetts
$255K -$36.2K -2 -14%
Tudor Investment Corp
47
Tudor Investment Corp
Connecticut
$210K -$90.5K -5 -33%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$201K – – –
Bank of America
49
Bank of America
North Carolina
$197K -$36.2K -2 -18%
MLICM
50
Metropolitan Life Insurance Company (MetLife)
New York
$190K +$163K +9 New
1
2
3 4 5

TPST Hedge Fund Activity: Q3 2016 in Review

80 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q3 2016, worth a combined $206M — up 38% from $149M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of TPST and 9 opened new positions — a net loss of 5 holders — while 17 trimmed existing stakes and 23 added.

The largest buyer was Portolan Capital Management, adding an estimated $2.86M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $2.3M sold.

  • 80 institutional investors held Tempest Therapeutics (TPST) as of Q3 2016, down from 85 in Q2 2016.
  • Funds reported $206M of Tempest Therapeutics stock for Q3 2016, up 38% quarter-over-quarter.
  • 9 funds opened new Tempest Therapeutics positions in Q3 2016 and 14 closed out, a net change of -5 holders.
  • The largest Tempest Therapeutics buyer in Q3 2016 was Portolan Capital Management, an estimated $2.86M added.
  • The largest Tempest Therapeutics seller in Q3 2016 was JP Morgan Chase, an estimated $2.3M sold.

Based on aggregated 13F filings for Q3 2016.